Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Short-term Investments: 2019-2025

Historic Short-term Investments for Revolution Medicines (RVMD) over the last 6 years, with Sep 2025 value amounting to $1.7 billion.

  • Revolution Medicines' Short-term Investments rose 27.14% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 27.14%. This contributed to the annual value of $1.7 billion for FY2024, which is 50.95% up from last year.
  • According to the latest figures from Q3 2025, Revolution Medicines' Short-term Investments is $1.7 billion, which was down 1.19% from $1.7 billion recorded in Q2 2025.
  • In the past 5 years, Revolution Medicines' Short-term Investments ranged from a high of $1.8 billion in Q1 2025 and a low of $330.0 million during Q1 2021.
  • In the last 3 years, Revolution Medicines' Short-term Investments had a median value of $1.3 billion in 2024 and averaged $1.2 billion.
  • Per our database at Business Quant, Revolution Medicines' Short-term Investments decreased by 21.09% in 2022 and then skyrocketed by 196.44% in 2024.
  • Quarterly analysis of 5 years shows Revolution Medicines' Short-term Investments stood at $468.6 million in 2021, then climbed by 3.20% to $483.5 million in 2022, then surged by 139.24% to $1.2 billion in 2023, then skyrocketed by 50.95% to $1.7 billion in 2024, then climbed by 27.14% to $1.7 billion in 2025.
  • Its Short-term Investments was $1.7 billion in Q3 2025, compared to $1.7 billion in Q2 2025 and $1.8 billion in Q1 2025.